Global /United States /Healthcare /Drug Manufacturers - Specialty & Generic /BRBR
chevron_leftBack
BellRing Brands, Inc. logo

BellRing Brands, Inc.

BRBR
NYSE: BRBR Delayed
17.54USD 3.6%
As of 7 June 2026, BellRing Brands, Inc. has a market cap of $1.02B USD, ranking #10601 globally and #2147 in the United States. It ranks #950 in the Healthcare sector, and #46 in the Drug Manufacturers - Specialty & Generic industry.
Global Rank
10601
Country Rank
2147
Sector Rank
950
Industry Rank
46
Key Stats
Market Cap
$1.02BUSD
Enterprise Value
$3.19BUSD
Revenue (TTM)
$2.32BUSD
EBITDA (TTM)
$339.5MUSD
Net Income (TTM)
$183.0MUSD
EBITDA Margin
15%
Profit Margin
7.9%
PE Ratio
12.1
Forward PE
8.9
PS Ratio
0.9
EV/EBITDA
9.4
Company Profile
Country (HQ)
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Darcy Davenport open_in_new
Employees
530
Founded
2019
IPO
17 Oct 2019
Website
bellring.com open_in_new
warningChart data may be delayed
1d 1w 1m 3m 6m 1y
3.6% 6.2% 14% -29% -44% -77%

News

Loading...

BRBR Analyst Forecasts

Loading...

Markets

Exchange Ticker Price
NYSE
MIC: XNYS
PRIMARY
BRBR
BellRing Brands Inc Class A
ISIN: US07831C1036
Shares Out.:
116.278M1 Shares Float: 114.225M2
TV:
SA:
YF:
GF:
NQ:
BA:
MS:
17.54 USD
Mexican Bolsa
MIC: XMEX
BRBR
BellRing Brands Inc Class A
ISIN: US07831C1036
TV:
SA:
YF:
GF:
BA:
MS:
200.00 MXN
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.

About BellRing Brands, Inc.

BellRing Brands, Inc., together with its subsidiaries, provides various nutrition products in the United States. The company offers ready-to-drink (RTD) protein shakes, other RTD beverages, protein powders, nutrition bars, and other products primarily under the Premier Protein and Dymatize brands. It distributes its products through club stores, food, drug and mass retailers, e-commerce, online and specialty retailers, and convenience stores channels. BellRing Brands, Inc. was incorporated in 2019 and is headquartered in Saint Louis, Missouri.

Similar Companies

Industry: Drug Manufacturers - Specialty & Generic (United States)
Name
Market Cap diff.
PE
$29.56B
3K%
-
INDV
$2.07B
1.54B GBP
103%
-
NDOI
$1.8B
77%
0.4
$1.76B
73%
-
$1.33B
30%
-
$471.83M
-54%
25.4
Industry: Drug Manufacturers - Specialty & Generic (Global)
Name
Market Cap diff.
PE
$37.66B
108.92B ILS
4K%
24.2
$15.86B
107.34B CNY
1K%
16.0
CIPLA
$11.12B
1.06T INR
990%
23.4
LUPIN
$11.0B
1.05T INR
979%
22.7
$9.1B
61.6B CNY
792%
80.6
$8.79B
7.57B EUR
762%
-
chevron_leftBack